Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Akston Biosciences
AddedFeb 15, 2024
UpdatedJun 18, 2026
Akston Biosciences

Akston Biosciences

US-based Akston Biosciences develops and manufactures innovative biologics, vaccines, and therapies.

HQ
Beverly, MA, US
Founded
2011
Overview
Compare
Fundraising
Employees
Website

Founded in Beverly, United States, Akston Biosciences leverages its novel fusion protein platform to develop and manufacture innovative biologics. The company focuses on creating breakthrough protein therapeutics, including vaccines, ultra-long-acting insulins, and therapies for autoimmune diseases. Akston's core mission is to accelerate the development and commercialization of these biologics, particularly in the Companion Animal Health market, through its integrated capabilities and strategic partnerships.

Notable affiliated individuals and investors include experts in biologics and animal health, though specific names are not provided. Key achievements include the establishment of a GMP manufacturing facility dedicated to Animal Health, significantly reducing the time from discovery to commercial manufacturing. Akston Biosciences has made a substantial impact by advancing the field of protein therapeutics and forming strategic partnerships that enhance its innovation and market reach.

Akston Biosciences - Similar Companies

GRO Biosciences logo

GRO Biosciences

grobio.com

Traverse Biosciences logo

Traverse Biosciences

Actio Biosciences logo

Actio Biosciences

actiobio.com

Animal Biosciences logo

Animal Biosciences

AcousticaBio logo

AcousticaBio

acoustica.bio

Abcombi Biosciences logo

Abcombi Biosciences

Actinobac Biomed logo

Actinobac Biomed

Extend Biosciences logo

Extend Biosciences

extendbio.com

Andson Biotech logo

Andson Biotech

andsonbiotech.com

Zebra Biologics logo

Zebra Biologics

Akeso Biomedical logo

Akeso Biomedical

Abacus Bioscience logo

Abacus Bioscience

Akttyva Therapeutics logo

Akttyva Therapeutics

akttyva.com

Astria Biosciences logo

Astria Biosciences

Sunflower Therapeutics logo

Sunflower Therapeutics

sunflowertx.com

Akston Biosciences - Quick Facts

Who are Akston Biosciences' competitors?

Companies similar to Akston Biosciences include GRO Biosciences, Traverse Biosciences, Actio Biosciences and Animal Biosciences.

When was Akston Biosciences founded?

Akston Biosciences was founded in 2011.

Where is Akston Biosciences' headquarters located?

Akston Biosciences' headquarters is located in Beverly, MA, US.

When was Akston Biosciences' last funding round?

Akston Biosciences' most recent funding round was for $5.2M (USD) in April 2022.

How much has Akston Biosciences raised to-date?

As of Apr 14, 2022, Akston Biosciences has raised a total of $46.6M (USD).

How many employees does Akston Biosciences have?

Akston Biosciences has 67 employees as of Feb 5, 2024.

Akston Biosciences - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biologics
  • Therapeutics
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified